Breast Carcinoma
|
disease |
Neoplasms; Skin and Connective Tissue Diseases
|
Neoplastic Process
|
6776
|
2793
|
0.400 |
None |
1.000 |
25 |
|
1991 |
2019 |
Malignant neoplasm of breast
|
disease |
Neoplasms; Skin and Connective Tissue Diseases
|
Neoplastic Process
|
6941
|
3417
|
0.400 |
None |
1.000 |
23 |
|
1992 |
2019 |
Osteitis Deformans
|
disease |
Musculoskeletal Diseases
|
Disease or Syndrome
|
134
|
58
|
0.340 |
None |
1.000 |
4 |
|
2010 |
2012 |
Mammary Neoplasms
|
group |
Neoplasms; Skin and Connective Tissue Diseases
|
Neoplastic Process
|
2780
|
385
|
0.330 |
None |
1.000 |
4 |
|
2002 |
2012 |
Mammary Neoplasms, Human
|
disease |
Neoplasms; Skin and Connective Tissue Diseases
|
Neoplastic Process
|
527
|
|
0.310 |
None |
1.000 |
2 |
|
1991 |
2006 |
Malignant mesothelioma
|
disease |
Neoplasms; Respiratory Tract Diseases
|
Neoplastic Process
|
420
|
12
|
0.310 |
None |
1.000 |
2 |
|
1989 |
2014 |
Mammary Carcinoma, Human
|
disease |
Neoplasms; Skin and Connective Tissue Diseases
|
Neoplastic Process
|
545
|
|
0.300 |
None |
1.000 |
1 |
|
2006 |
2006 |
Osteopetrosis
|
disease |
Musculoskeletal Diseases
|
Disease or Syndrome
|
74
|
5
|
0.290 |
None |
1.000 |
10 |
|
1993 |
2018 |
Glioma
|
disease |
Neoplasms
|
Neoplastic Process
|
3097
|
353
|
0.230 |
None |
1.000 |
4 |
|
1998 |
2019 |
Systemic Scleroderma
|
disease |
Skin and Connective Tissue Diseases
|
Disease or Syndrome
|
979
|
287
|
0.230 |
None |
1.000 |
3 |
|
2013 |
2018 |
Hypercholesterolemia
|
disease |
Nutritional and Metabolic Diseases
|
Disease or Syndrome
|
489
|
123
|
0.200 |
None |
1.000 |
1 |
|
1997 |
1997 |
Malignant Glioma
|
disease |
Neoplasms
|
Neoplastic Process
|
724
|
22
|
0.200 |
None |
1.000 |
1 |
|
2005 |
2005 |
Anti-Basement Membrane Glomerulonephritis
|
disease |
Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases
|
Disease or Syndrome
|
39
|
|
0.200 |
None |
1.000 |
1 |
|
2009 |
2009 |
Graft Rejection
|
phenotype |
|
Organ or Tissue Function
|
47
|
|
0.200 |
None |
1.000 |
1 |
|
2002 |
2002 |
Albuminuria
|
phenotype |
Pathological Conditions, Signs and Symptoms; Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases
|
Finding
|
76
|
59
|
0.200 |
None |
1.000 |
1 |
|
1996 |
1996 |
Neoplasms
|
group |
Neoplasms
|
Neoplastic Process
|
10161
|
1644
|
0.100 |
None |
0.966 |
59 |
|
1992 |
2019 |
Neoplasm Metastasis
|
phenotype |
Pathological Conditions, Signs and Symptoms; Neoplasms
|
Neoplastic Process
|
6385
|
327
|
0.100 |
None |
1.000 |
21 |
|
1997 |
2019 |
Malignant Neoplasms
|
group |
Neoplasms
|
Neoplastic Process
|
8621
|
1641
|
0.100 |
None |
0.950 |
20 |
|
1996 |
2019 |
Primary malignant neoplasm
|
group |
Neoplasms
|
Neoplastic Process
|
8221
|
1374
|
0.100 |
None |
0.947 |
19 |
|
1996 |
2019 |
Tumor Cell Invasion
|
phenotype |
|
Neoplastic Process
|
6626
|
169
|
0.100 |
None |
0.941 |
17 |
|
1992 |
2017 |
Carcinoma, Ovarian Epithelial
|
disease |
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Endocrine System Diseases
|
Neoplastic Process
|
2841
|
327
|
0.100 |
None |
1.000 |
11 |
|
1988 |
2012 |
Leukemia, Myelocytic, Acute
|
disease |
Neoplasms
|
Neoplastic Process
|
3111
|
6892
|
0.100 |
None |
1.000 |
10 |
|
1987 |
2019 |
White Blood Cell Count procedure
|
phenotype |
|
Laboratory Procedure
|
681
|
1322
|
0.100 |
None |
1.000 |
2 |
1
|
2016 |
2019 |
High density lipoprotein measurement
|
phenotype |
|
Laboratory Procedure
|
545
|
1440
|
0.100 |
None |
1.000 |
1 |
1
|
2018 |
2018 |
Blood Protein Measurement
|
phenotype |
|
Laboratory Procedure
|
1156
|
2575
|
0.100 |
None |
1.000 |
1 |
1
|
2018 |
2018 |